Pathology of Alcoholic Liver Disease with Special Emphasis on Alcoholic Hepatitis

  • H. Ishii
  • I. Okazaki
  • M. Tsuchiya

Abstract

It has been widely recognized that alcoholism is one of the major sociomedical problems of modern society. It is also known that excessive alcohol intake is a factor in a significant percentage of all deaths, roughly 10% in the United States. It is associated with half of all traffic deaths, many involving teenagers. Cirrhosis of the liver, which ranks among the ten leading causes of death, is largely attributable to excessive alcohol consumption (Lieber 1978; Eckardt et al. 1981).

Keywords

Hepatitis Lactate Proline Fibril Colchicine 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Afshami P, Littenberg GD, Wollman J, Kaplowitz N (1978) Significance of microscopic cholangitis in alcoholic liver disease. Gastroenterology 75: 1045–1050Google Scholar
  2. Bailey RJ, Krasner N, Eddleston ALWF, Williams R, Tee DEH, Doniach D, Kennedy LA, Bachelor JR (1976) Histocompatibility antigens, autoantibodies, and immunoglobulins in alcoholic liver disease. Br Med J 2: 727–729PubMedGoogle Scholar
  3. Basile A, Vitale G, Macor C, Scudeller G (1981) Hepatitis B virus infection in alcoholic cirrhosis. Br Med J 282: 1705–1706Google Scholar
  4. Bell H, Nordhagen R (1978) Association between HLA-BW40 and alcoholic liver diseases with cirrhosis. Br Med J 1: 822PubMedGoogle Scholar
  5. Bernstein IM, Webster KH, Williams RC Jr, Strickland RG (1974) Reduction in circulating T lymphocytes in alcoholic liver disease. Lancet 2: 488–490PubMedGoogle Scholar
  6. Berry RE Jr, Boland JP (1979) The economic cost of alcohol abuse. Free Press, New YorkGoogle Scholar
  7. Biava C (1964) Mallory alcoholic hyaline: a heretofore unique lesion of hepatocellular ergastoplasm. Lab Invest 13: 301–320Google Scholar
  8. Birschbach HR, Harinasuta W, Zimmerman HJ (1974) Alcoholic steatonecrosis. II. Prospective study of prevalence of Mallory bodies in biopsy specimens and comparison of severity of hepatic disease in patients with and without this histological feature. Gastroenterology 66: 1195–1202PubMedGoogle Scholar
  9. Bjøneboe M, Prytz H (1976) The mononuclear phagocyte functions of the liver. In: Ferguson A, MacSween RNM (eds) Immunologic Aspects of the liver and intestinal tract. Garden City Press, Lancaster, pp 251–289Google Scholar
  10. Bjøneboe M, Prytz H, Orskov F (1972) Antibodies to intestinal microbes in serum of patients with cirrhosis of the liver. Lancet 1: 58–60Google Scholar
  11. Brunt PW, Kew MC, Shemer PJ, Sherlock S (1974) Studies in alcoholic liver disease in Britain. I. Clinical and pathological patterns related to natural history. Gut 15: 52–58PubMedGoogle Scholar
  12. Buffet C, Attali P, Papoz L, Chaput JC, Etienne JP (1982) Evidence for previous hepatitis B virus infection in alcoholic cirrhosis. Digest Dis Sci 27: 473–474PubMedGoogle Scholar
  13. Chalmers DM, Bullen AW, Levi AJ (1981) Evidence for previous hepatitis B virus infection in alcoholic cirrhosis. Br Med J 282: 819Google Scholar
  14. Cherrick GR, Potheir L, Dufour JJ, Sherlock S (1958) Immunologic response to tetanus toxoid inoculation in patients with hepatic cirrhosis. N Engl J Med 261: 340–342Google Scholar
  15. Christoffersen P, Poulsen H (1979) Alcoholic liver disease. In: MacSween RNM, Anthony PP, Scheuer PJ (eds) Pathology of the liver. Churchill Livingstone, Edinburgh, pp 232–247Google Scholar
  16. Christoffersen P, Braendstrup O, Juhl E, Poulsen H (1971) Lipogranulomas in human liver biopsies with fatty change. Acta Pathol Microbiol Scand [A] 79: 150–158Google Scholar
  17. Cochrane AMG, Moussouros A, Portmann B, McFarlane IG, Thomson AD, Eddieston ALWF, Williams R (1977) Lymphocyte cytotoxicity for isolated hepatocytes in alcoholic liver disease. Gastroenterology 72: 918–923PubMedGoogle Scholar
  18. Delacroix DL, Reynaert M, Pauwels S, Geubel AP, Vaerman JP (1982) High serum levels of secretory IgA in liver disease. Dig Dis Sci 27: 333–340PubMedGoogle Scholar
  19. Denk H, Eckerstorfer R (1977) Colchicine-induced Mallory body formation in the mouse. Lab Invest 36: 563–565PubMedGoogle Scholar
  20. Denk H, Franke WW, Eckerstorfer R (1979) Formation and involution of Mallory bodies (“alcoholic hyalin”) in murine and human liver revealed by immunofluorescence microscopy with antibodies to prekeratin. Proc Natl Acad Sci USA 76: 4112–4116PubMedGoogle Scholar
  21. Denk H, Franke WW, Dragosics B, Zeiler I (1981) Pathology of cytoskeleton of liver cells: demonstration of Mallory bodies (alcoholic hyalin) in murine and human hepatocytes by immunofluorescence microscopy using antibodies to cytokeratin polypeptides from hepatocytes. Hepatology 1: 9–20PubMedGoogle Scholar
  22. Eckardt MJ, Harford TC, Kaelber CT, Parker ES, Rosenthal LS, Ryback RS, Salmoiraghi GC, Vanderveen EV, Warren K (1981) Health hazards associated with alcohol consumption. JAMA 246: 648–666PubMedGoogle Scholar
  23. Edmondson HA, Peters RL, Reynolds TB, Kuzma DT (1963) Sclerosing hyaline necrosis of the liver in the chronic alcoholic. A recognizable clinical syndrome. Ann Intern Med 59: 646–673PubMedGoogle Scholar
  24. Edmondson HA, Peters RL, Frankel HH, Borowsky S (1967) The early stage of liver injury in the alcoholic. Medicine 46: 119–129PubMedGoogle Scholar
  25. Feinman L, Lieber CS (1972) Hepatic collagen metabolism: effect of alcohol consumption in rats and baboons. Science 176: 795PubMedGoogle Scholar
  26. Fessler JH, Fessler LI (1978) Biosynthesis of procollagen. Annu Rev Biochem 47: 129–162PubMedGoogle Scholar
  27. Flax MH, Tisdale WA (1964) An electron microscopic study of alcoholic hyalin. Am J Pathol 44: 441–453PubMedGoogle Scholar
  28. Franke WW, Denk H, Schmid E, Osborn M, Weber K (1979) Ultrastructural biochemical and immunologic characterization of Mallory bodies in griseofulvin-treated mice. Fimbriated rods of filaments containing prekeratin-like polypeptides. Lab Invest 40: 207–220Google Scholar
  29. Frei A, Zimmerman A, Weigand K (1982) Serum procollagen-III-aminopeptide (pp) as index of liver fibrosis — new morphometric evidence. Hepatology 2: 733Google Scholar
  30. French SW (1981) The Mallory body: structure, composition and pathogenesis. Hepatology 1: 76–83PubMedGoogle Scholar
  31. French SW, Davies PL (1975) The Mallory body in the pathogenesis of alcoholic liver disease. In: Khanna JM, Israel Y, Kalent H (eds) Alcoholic liver pathology. Addiction Research Foundation, Toronto, pp 113–114Google Scholar
  32. French SW, Sim JS, Franks KE (1977) Alcoholic hepatitis. In: Fisher MM, Rankin JG (eds) Alcohol and the liver. Plenum, New York, pp 261–288Google Scholar
  33. Galambos JT (1972) Natural history of alcoholic hepatitis. III. Histological changes. Gastroenterology 63: 1026–1035PubMedGoogle Scholar
  34. Gerber MA, Popper H (1972) Relation between central canals and portal tracts in alcoholic hepatitis. A contribution to the pathogenesis of cirrhosis in alcoholics. Human Pathol 3: 199–207Google Scholar
  35. Gluud C, Aldershvile J, Dietrichson O, Hardt F, Iversen K, Juhl E, Nielsen JO, Ryder LP, Skinhoj P, Srejgaard A (1980) A human leucozyte antigen in patients with alcoholic liver cirrhosis. Scand J Gastroenterology 15: 337–341Google Scholar
  36. Goldberg SJ, Mendenhall CL, Connell AM, Chedid A (1977) “Nonalcoholic” chronic hepatitis in the alcoholic. Gastroenterology 72:598–604Google Scholar
  37. Goudeau A, Maupas P, Dubois F, Coursaget P, Bougnoux P (1981) Hepatitis B infection in alcoholic liver disease and primary hepatocellular carcinoma in France. Prog Med Virol 27: 26–34PubMedGoogle Scholar
  38. Hall EM, Ophulus W (1925) Progressive alcoholic cirrhosis. Report of four cases. Am J Pathol 1: 477–493PubMedGoogle Scholar
  39. Harinasuta U, Zimmerman HJ (1971) Alcoholic steatonecrosis. I. Relationship between severity of hepatic disease and presence of Mallory bodies in the liver. Gastroenterology 60: 1036–1046PubMedGoogle Scholar
  40. Havens WP Jr (1959) Liver disease and antibody formation. Int Arch Allergy Appl Immunol 14: 75–83PubMedGoogle Scholar
  41. Helman RA, Temko MH, Nye SW, Fallon HJ (1971) Alcoholic hepatitis: natural history and evaluation of prednisolone therapy. Ann Intern Med 74: 311–321PubMedGoogle Scholar
  42. Inoue K (1979) The clinicopathological features of the alcoholic liver injury in Japan and its etiological relationship to hepatitis B virus. Gastroenterol Jpn 12: 230–240Google Scholar
  43. Iseri OA, Gottlieb LS (1971) Alcoholic hyaline and megamitochondria as separate and distinct entities in liver disease associated with alcoholism. Gastroenterology 60: 1027–1035PubMedGoogle Scholar
  44. Ishii H, Kanno T, Shigeta Y, Yasuraoka S, Kano S, Takeshita E, Tsuchiya M (1976) Hepatic gamma glutamyl transpeptidase activity: its activation by chronic ethanol administration. Gastroenterology 71: A–20/913Google Scholar
  45. Ishii H, Yasuraoka S, Shigeta Y, Kamiya T, Okuno F, Miyamoto K, Tsuchiya M (1978) Hepatic and intestinal gamma glutamyl transpeptidase activity: its activation by chronic ethanol administration. Life Sci 23: 1393–1398PubMedGoogle Scholar
  46. Ishii H, Okuno F, Shigeta Y, Tsuchiya M (1980) Significance of serum gamma glutamyl transpeptidase as a marker of alcoholism. Pharmacol Biochem Behav 13: 95–99PubMedGoogle Scholar
  47. Ishii H, Inagaki Y, Tsuchimoto K, Yamauchi H, Takagi S, Shigeta Y, Tsuchiya M (1982) Increased incidence of “non alcoholic” chronic hepatitis in alcoholics: evidence for autoantibodies to hepatocyte and antibody dependent cell-mediated cytotoxicity ( ADCC ). Hepatology 2: 704Google Scholar
  48. Iturriaga H, Pereda T, Estevez A, Ugarte G (1977) Serum immunoglobulin changes in alcoholic patients, Ann Clin Res 9: 39–43PubMedGoogle Scholar
  49. Jensen DMBS, McFarlane IG, Portmann BS, Eddleston ALWF, Williams R (1978) Detection of antibodies detected against a liver-specific membrane lipoprotein in patients with acute and chronic active hepatitis. N Engl J Med 299: 1–7PubMedGoogle Scholar
  50. Karasawa T, Shikata T, Kushida T, Kaneda H, Ohknbo H (1979) Pathological study on alcoholic liver diseases in high and low incidence countries: comparison between Cincinnati, USA and Tokyo, Japan. Kanzo 20: 115–123Google Scholar
  51. Klion FM, Schaffner F (1968) Ultrastructural studies in alcoholic liver disease. Digestion 1: 2–14PubMedGoogle Scholar
  52. Kowaloff FM, Phang JM, Granger AS, Downing SJ (1977) Regulation of proline oxidase activity by lactate. Pro Natl Acad Sci USA 74: 5368–5371Google Scholar
  53. Lane BP, Lieber CS (1966) Ultrastructural alterations in human hepatocytes following ingestion of ethanol with adequate diets. Am J Pathol 49: 593–603PubMedGoogle Scholar
  54. Lang JM, Ruscher H, Hasselmann JP, Grandjean P, Bigel P, Mayer S (1980) Decreased autologous rosette-forming T lymphocytes in alcoholic cirrhosis. Absence of correlation with other T cell markers and with delayed cutaneous hypersensitivity. Int Arch Allergy Appl Immunol 61: 337–343PubMedGoogle Scholar
  55. Leevy CM (1962) Fatty liver: a study of 270 patients with biopsy proven fatty liver and a review of the literature. Medicine 41: 249–276PubMedGoogle Scholar
  56. Leevy CM, Popper H, Sherlock S (1976) Diseases of the liver and biliary tract. Standardization of nomenclature, diagnostic criteria and diagnostic methodology. DHEW Publication No. (NIH) 76–725Google Scholar
  57. Leevy CM, Kanagasundaram N, Matsumoto K, Chen T (1979) Alcoholic hyalin and immunologic reactivity. In: Eddleston ALWF, Weber JCP, Williams R (eds) Immune reactions in liver disease. Pitman Medical, Tunbridge Wells, pp 195–207Google Scholar
  58. Lieber CS (1978) A public health strategy against alcoholism and its complications. Am J Med 65: 722–725PubMedGoogle Scholar
  59. Lieber CS (1981) Metabolism and metabolic effects of ethanol. Semin Liver Dis 1: 189–202PubMedGoogle Scholar
  60. Lieber CS (1982) Medical disorders of alcoholism: pathogenesis and treatment. Saunders, Philadelphia, p 263Google Scholar
  61. Lieber CS (1983) Precursor lesions of cirrhosis. Alcoholism 18: 5–20Google Scholar
  62. Lindy S, Pedersen FB, Turto H, Uitoo J (1971) Lactate, lactate dehydrogenase and protocollagen proline hydroxylase in rat skin autograft. Hoppe Seylers Z Physiol Chem 352: 113–118PubMedGoogle Scholar
  63. Lishner MW, Alexander JF, Galambos JT (1971) Natural history of alcoholic hepatitis. I. The acute disease. Am J Dig Dis 16: 481–494Google Scholar
  64. Lundy J, Raaf JH, Deakins S, Wanebo HJ, Jacobs DA, Lee T-d, Jacobowitz D, Spear C, Oettgen HF (1975) The acute and chronic effects of alcohol on the human immune system. Surg Gynecol Obstet 141: 212–219PubMedGoogle Scholar
  65. Mallory FB (1911) Cirrhosis of the liver. Five different types of lesions from which it may arise. Bull Johns Hopkins Hospital 22: 69–75Google Scholar
  66. Mann SW, Fuller GC, Rodil JV, Vidins EI (1979) Hepatic prolyl hydroxylase and collagen synthesis in patients with alcoholic liver disease. Gut 20: 825–832PubMedGoogle Scholar
  67. Maruyama K, Feinman L, Okazaki I, Lieber CS (1981) Direct measurement of neutral collagenase activity in liver homogenates from baboons and humans. Biochim Biophys Acta 658: 124–131PubMedGoogle Scholar
  68. Maruyama K, Feinman L, Fainsilber Z, Nakano M, Okazaki I, Lieber CS (1982) Mammalian collagenase increases in early alcoholic liver disease and decrease with cirrhosis. Life Sci 30: 1379–1384PubMedGoogle Scholar
  69. Melendez M, Vargas-Tank L, Fuentes C, Armas-Merino R, Castillo D, Wolff C, Wegmann ME, Soto J (1979) Distribution of HLA histocompatibility antigens, ABO blood groups and RH antigens in alcoholic liver disease. Gut 20: 288–290Google Scholar
  70. Mills PR, Pennington TH, Kay P, McSween RNM, Watkinson G (1979) Hepatitis Bs antibody in alcoholic cirrhosis. J Clin Pathol 32: 778–782PubMedGoogle Scholar
  71. Mills PR, Follett EAC, Urguhart GeD, Clements G, Watkinson G, MacSween RNM (1981) Evidence for previous hepatitis B virus infection in alcoholic cirrhosis. Br Med J 282: 437–438Google Scholar
  72. Miyamoto K, Ishii H, Takata H, Takagi S, Shigeta Y, Sekiguchi S, Suyama K, Kohno H, Tsuchiya M (1983) Association of HLA-B40 and DRW 9 with Japanese alcoholic liver cirrhosis. Pharmacol Biochem Behav [Suppl 1] 18: 467–471Google Scholar
  73. Morgan MY, Ross MGR, Ng CM, Adams DM, Thomas HC, Sherlock S (1980) HLA-B8, immunoglobulins, and antibody responses in alcohol-related liver disease. J Clin Pathol 33: 488–492PubMedGoogle Scholar
  74. Morton JA, Fleming KA, Trowell JM, McGee JO’D (1980) Mallory bodies–immunohistochemical detection by antisera to unique non-prekeratin components. Gut 21: 727–733PubMedGoogle Scholar
  75. Mutchnick MG, Lederman HM, Missirian A, Hohnson AG (1981) In vitro synthesis of IgG by peripheral blood lymphocytes in chronic liver disease. Clin Exp Immunol 43: 370–375PubMedGoogle Scholar
  76. Nakano M, Worner TM, Lieber CS (1982) Perivenular fibrosis in alcoholic liver injury: ultrastructure and histologic progression. Gastroenterology 83: 777–785PubMedGoogle Scholar
  77. Nei J, Matsuda Y, Takada A (1983) Chronic hepatitis induced by alcohol. Dig Dis Sci 28: 207–215PubMedGoogle Scholar
  78. Niemela O, Risteli L, Sotaniemi EA (1983) Aminoterminal propeptide of type III procollagen in serum in alcoholic liver disease. Gastroenterology 85: 254–259PubMedGoogle Scholar
  79. Okazaki I, Feinman L, Lieber CS (1977) Hepatic mammalian collagenase: development of an assay and demonstration of reversal activity after ethanol consumption. Gastroenterology 73: 1236Google Scholar
  80. Okazaki I, Feinman L, Maruyama K, Fainsilber Z, Nakano M, Lieber CS (1983) Development of an assay for mammalian hepatic collagenase and study of the effect of ethanol on enzyme activity. In: Lieber CS (ed) Biological approach to alcoholism. U.S. Department of Health and Human Services (ADM 83–1261), Washington, D.C., pp 392–398Google Scholar
  81. Paronetto F (1981) Immunologic factors in alcoholic liver disease. Semin Liver Dis 1: 232–243PubMedGoogle Scholar
  82. Petersen PU (1977) Alcoholic hyalin, microfilaments and microtubules in alcoholic hepatitis. Acta Pathol Microbiol Scand 85: 384–394Google Scholar
  83. Pettigrew NM, Goudie RB, Russell RI (1972) Evidence for a role of hepatitis virus B in chronic alcoholic liver disease. Lancet 2: 724PubMedGoogle Scholar
  84. Popper H (1977) The pathogenesis of alcoholic cirrhosis. In: Fisher MM, Rankin JG (eds) Alcohol and the liver. Plenum, New York, pp 289–305Google Scholar
  85. Popper H, Lieber CS (1980) Histogenesis of alcoholic fibrosis and cirrhosis in the baboon. Am J Path 98: 695–716PubMedGoogle Scholar
  86. Popper H, Szanto PB, Parathasarathy M (1955) Florid cirrhosis - a review of 35 cases. Am J Clin Pathol 25: 889–901PubMedGoogle Scholar
  87. Porta EA, Hartroft WS, de la Iglesia FA (1967) Structural and ultrastructural hepatic lesions associated with acute and chronic alcoholism in man and experimental animals. In: Maickel RP (ed) Biochemical factors in alcoholism. Pergamon, Oxford, pp 201–238Google Scholar
  88. Rohde H, Vargas L, Hahn E, Kalbfleisch H, Bruguera M, Timpl R (1979) Radioimmunoassay for type III procollagen peptide and its application to human liver disease. Eur J Clin Invest 9: 451–459PubMedGoogle Scholar
  89. Rubin E, Lieber CS (1968) Alcohol-induced hepatic injury in nonalcoholic volunteers. N Engl J Med 278: 869–876PubMedGoogle Scholar
  90. Rubin E, Lieber CS (1974) Fatty liver, alcoholic hepatitis and cirrhosis produced by alcohol in primates. N Engl J Med 290: 128–135PubMedGoogle Scholar
  91. Scott BB, Rajah SM, Losowsky MS (1977) Histocompatibility antigens in chronic liver disease. Gastroenterology 72: 122–125PubMedGoogle Scholar
  92. Smith WI Jr, Van Thiel DH, Whiteside T, Janoson B, Magovern I, Puet T, Rabin BS (1980) Altered immunity in male patients with alcoholic liver disease: evidence for defective immune regulation. Alcoholism Clin Exp Res 4: 199–206Google Scholar
  93. Sorrell MF, Leevy CM (1972) Lymphocyte transformation and alcoholic liver injury. Gastroen¬terology 63: 1020–1025Google Scholar
  94. Svoboda DJ, Manning RT (1964) Chronic alcoholism with fatty metamorphosis of the liver. Am J Pathol 44: 645–662PubMedGoogle Scholar
  95. Takagi S (1979) Altered humoral and cell-mediated immunity in chronic alcoholics. Its relation to the development of liver injury. J. Keio Med. Soc. 76: 184–195Google Scholar
  96. Theofilopoulos AN, Dixon FI (1980) Immune complexes in human diseases. Am J Pathol 100: 531–594Google Scholar
  97. Thomas HC, Freni M, Sanchez-Tapias J, DeVilliers D, Jain S, Sherlock S (1976) Peripheral blood lymphocyte populations in chronic liver disease. Clin Exp Immunol 26: 222–227PubMedGoogle Scholar
  98. Tsuchimoto K (1982) Detection of antibody and antibody dependent cell-mediated cytotoxicity (ADCC) against Chang liver cell in alcohol liver disease. Jpn J Gastroenterol 79: 1581–1588Google Scholar
  99. Van Waes L, Lieber CS (1977a) Early perivenular sclerosis in alcoholic fatty liver: an index of progressive liver injury. Gastroenterology 73: 646–650PubMedGoogle Scholar
  100. Van Waes L, Lieber CS (1977b) Glutamate dehydrogenase, a reliable marker of liver cell necrosis in the alcoholic. Br Med J 2: 1508–1510PubMedGoogle Scholar
  101. Villa E, Rubbiani L, Barchi T, Ferretti I, Grisendi A, De Palma M, Bellentani S, Manerti F (1982) Susceptibility of chronic symptomless HBsAg carriers to ethanol-induced hepatic damage. Lancet 2: 1243–1244PubMedGoogle Scholar
  102. Wands JR, Dienstag JL, Weake JR, Koff RS (1978) Proliferative and secretory B cell activity in severe alcoholic liver disease. Gastroenterology 75: 992Google Scholar
  103. Yokoo H, Minick OT, Batti F, Kent G (1972) Morphologic variants of alcoholic hyalin. Am J Pathol 69: 25–40PubMedGoogle Scholar
  104. Zakim D, Boyer TD, Montgomery C, Kanas N (1982) Alcoholic liver disease. In: Zakim D, Boyer T (eds) A texbook of liver disease. Saunders, Philadelphia, pp 739–789Google Scholar
  105. Zetterman RK, Leevy CM (1975) Immunologic reactivity and alcoholic liver disease. Bull N Y Acad Med 51: 533–544PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1985

Authors and Affiliations

  • H. Ishii
    • 1
  • I. Okazaki
    • 1
  • M. Tsuchiya
    • 1
  1. 1.Department of Internal Medicine Division of Gastroenterology and Department of Preventive Medicine and Public Health, School of MedicineKeio UniversityTokyoJapan

Personalised recommendations